Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Drug Design Targeting T-Cell Factor-Driven Epithelial-Mesenchymal Transition as a Therapeutic Strategy for Colorectal Cancer.

Abraham AD, Esquer H, Zhou Q, Tomlinson N, Hamill BD, Abbott JM, Li L, Pike LA, Rinaldetti S, Ramirez DA, Lunghofer PJ, Gomez JD, Schaack J, Nemkov T, D'Alessandro A, Hansen KC, Gustafson DL, Messersmith WA, LaBarbera DV.

J Med Chem. 2019 Nov 18. doi: 10.1021/acs.jmedchem.9b01065. [Epub ahead of print]

PMID:
31675229
2.

Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers.

Schweppe RE, Pozdeyev N, Pike LA, Korch C, Zhou Q, Sams SB, Sharma V, Pugazhenthi U, Raeburn C, Albuja-Cruz MB, Reigan P, LaBarbera DV, Landa I, Knauf JA, Fagin JA, Haugen BR.

Mol Cancer Res. 2019 May;17(5):1036-1048. doi: 10.1158/1541-7786.MCR-18-1026. Epub 2019 Feb 7.

PMID:
30733375
3.

FAK Expression, Not Kinase Activity, Is a Key Mediator of Thyroid Tumorigenesis and Protumorigenic Processes.

Kessler BE, Sharma V, Zhou Q, Jing X, Pike LA, Kerege AA, Sams SB, Schweppe RE.

Mol Cancer Res. 2016 Sep;14(9):869-82. doi: 10.1158/1541-7786.MCR-16-0007. Epub 2016 Jun 3.

4.

Characterization of thyroid cancer cell lines in murine orthotopic and intracardiac metastasis models.

Morrison JA, Pike LA, Lund G, Zhou Q, Kessler BE, Bauerle KT, Sams SB, Haugen BR, Schweppe RE.

Horm Cancer. 2015 Jun;6(2-3):87-99. doi: 10.1007/s12672-015-0219-0. Epub 2015 Mar 24.

5.

Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer.

Morrison JA, Pike LA, Sams SB, Sharma V, Zhou Q, Severson JJ, Tan AC, Wood WM, Haugen BR.

Mol Cancer. 2014 Mar 19;13:62. doi: 10.1186/1476-4598-13-62.

6.

Targeted inhibition of Src kinase with dasatinib blocks thyroid cancer growth and metastasis.

Chan CM, Jing X, Pike LA, Zhou Q, Lim DJ, Sams SB, Lund GS, Sharma V, Haugen BR, Schweppe RE.

Clin Cancer Res. 2012 Jul 1;18(13):3580-91. doi: 10.1158/1078-0432.CCR-11-3359. Epub 2012 May 14.

7.

PPARĪ³ Promotes Growth and Invasion of Thyroid Cancer Cells.

Wood WM, Sharma V, Bauerle KT, Pike LA, Zhou Q, Fretwell DL, Schweppe RE, Haugen BR.

PPAR Res. 2011;2011:171765. doi: 10.1155/2011/171765. Epub 2011 Dec 12.

8.

Screening for diabetes.

Pike LA, Crombie DL.

Br J Gen Pract. 1997 Nov;47(424):751-2. No abstract available.

9.

Effect of patient age on tests of the acute-phase response.

Caswell M, Pike LA, Bull BS, Stuart J.

Arch Pathol Lab Med. 1993 Sep;117(9):906-10.

PMID:
7690224
10.

The effects of verapamil and propranolol on quality of life in hypertension.

Fletcher AE, Chester PC, Hawkins CM, Latham AN, Pike LA, Bulpitt CJ.

J Hum Hypertens. 1989 Apr;3(2):125-30.

PMID:
2668524
11.

Attitudes of Asian patients in Birmingham to general practitioner services.

Jain C, Narayan N, Narayan K, Pike LA, Clarkson ME, Cox IG, Chatterjee J.

J R Coll Gen Pract. 1985 Sep;35(278):416-8.

12.

General practice--a quantitative study, 1. Workload and morbidity variation.

Beaumont CD, Pike LA.

Ecol Dis. 1983;2(1):45-53.

PMID:
6678763
13.
14.

Organising health education.

Pike LA.

Br Med J (Clin Res Ed). 1982 Mar 20;284(6319):874-5. No abstract available.

15.

A by-pass card for infants.

Pike LA.

Practitioner. 1981 Jul;225(1357):956-7. No abstract available.

PMID:
7312773
16.

Teaching parents about child health using a practice booklet.

Pike LA.

J R Coll Gen Pract. 1980 Sep;30(218):517-9.

17.

Familial systemic lupus erythematosus--a case report.

Pike LA.

J R Coll Gen Pract. 1977 Mar;27(176):171-2. No abstract available.

18.

Improving doctor-patient communication in general practice.

Ley P, Whitworth MA, Skilbeck CE, Woodward R, Pinsent RJ, Pike LA, Clarkson ME, Clark PB.

J R Coll Gen Pract. 1976 Oct;26(171):720-4. No abstract available.

19.

Screening the elderly in general practice.

Pike LA.

J R Coll Gen Pract. 1976 Sep;26(170):698-703.

20.

Health education in general practice.

Pike LA.

Community Health (Bristol). 1973 Jan-Feb;4(4):179-84. No abstract available.

PMID:
4119614
21.

Screening middle-aged men in a general practice.

Pike LA.

Practitioner. 1972 Nov;209(253):690-5. No abstract available.

PMID:
4635627
22.

Comparison of mortality in the elderly at home and in a welfare home.

Pike LA.

J R Coll Gen Pract. 1972 Sep;22(122):648-50. No abstract available.

23.

Follow-up after abortion.

Pike LA.

Br Med J. 1971 Jun 26;2(5764):767. No abstract available.

24.

The consumer demand for health education.

Pike LA.

J R Coll Gen Pract. 1971 Mar;21(104):156-60. No abstract available.

25.

A screening programme for the elderly in a general practice.

Pike LA.

Practitioner. 1969 Dec;203(218):805-12. No abstract available.

PMID:
5356396
26.

Group health education in a general practice.

Pike LA.

J Coll Gen Pract. 1965 Nov;10(3):317-8. No abstract available.

27.

A general practitioner looks at diabetes.

PIKE LA.

Public Health. 1963 Mar;77:165-9. No abstract available.

PMID:
13943554
28.

The health visitor in a general practice.

PINSENT RJ, PIKE LA, MORGAN RH, MANSELL JM.

Br Med J. 1961 Apr 8;1(Suppl 2933):123-7. No abstract available.

29.

2. Lecture Discussions to Patients.

Pike LA.

J Coll Gen Pract Res Newsl. 1959 Aug;2(3):270-271. No abstract available.

30.

Further observations on ABO blood-group frequencies and toxaemia of pregnancy.

DICKINS AM, RICHARDSON JR, PIKE LA, ROBERTS JA.

Br Med J. 1956 Apr 7;1(4970):776-7. No abstract available.

31.

ABO blood groups and toxaemia of pregnancy.

PIKE LA, DICKINS AM.

Br Med J. 1954 Aug 7;2(4883):321-3. No abstract available.

Supplemental Content

Support Center